Concepedia

Myriam Jaraíz-Rodríguez

MJ

5

Publications

267

Citations

5

H-Index

2016

Active since

Affiliations

Universidad de Salamanca(Current)

Instituto de Estudios de Ciencias de la Salud de Castilla y León

Instituto de Investigación Biomédica de Salamanca

Myriam Jaraíz-Rodríguez is an author at Universidad de Salamanca specializing in tumor biology, glioma, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2020

5

Publications

5

A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

Myriam Jaraíz-Rodríguez, M.D. Tabernero, María González-Tablas et al. · Stem Cell Reports · 2017 · 81 citations · Full text

, , +9

Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

Ana González-Sánchez, Myriam Jaraíz-Rodríguez, Marta Domínguez-Prieto et al. · Oncotarget · 2016 · 62 citations · Full text

, , +19

Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

Myriam Jaraíz-Rodríguez, Rocío Talaverón, Laura García-Vicente et al. · Neuro-Oncology · 2019 · 51 citations · Full text

A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity

Ester Gangoso, Rocío Talaverón, Myriam Jaraíz-Rodríguez et al. · Frontiers in Molecular Neuroscience · 2017 · 37 citations · Full text

Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

Sara G. Pelaz, Myriam Jaraíz-Rodríguez, Andrea Álvarez-Vázquez et al. · EBioMedicine · 2020 · 36 citations · Full text

Rows per page

1–5 of 5